Organ and Tissue Transplantation Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Organ and Tissue Transplantation Market: by Product (Immunosuppressants, Preservation Solutions, and Tissue Products), By Application (Organ Transplantation (Heart, Lungs, Liver, Kidney, Intestine/Small Bowel, Pancreas), Tissue Transplantation (Skin Transplantation, Cellular Transplantation, Cornea, Vascular Transplantation, Bone Graft Transplantation)), By End User (Hospitals, Transplantation Centers, Others), and Geography (North America, Latin America, Europe, Middle East and Africa, Asia Pacific)

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global organ and tissue transplantation market is expected to grow at a CAGR of 7.7% during the forecast period 2021 to 2027. Organ and tissue transplantation saves many lives and restores the essential functions of the body. The organ transplantation is the medical procedure in which the organ is removed from one body and is placed in the recipient’s body. The organs which can be transplanted include kidneys, heart, intestine, thymus, liver, lings and pancreas. The tissues include skin, cornea, heart valve, tendons and bones. The organ failure generally occurs owing to several conditions such as poising, serious trauma, drug abuse, and so on. The organ transplantation is the final stage of the treatment in organ failure. The organ and tissue transplantation market is also being boosted by the launch of technologically improved products and an increase in the number of tissue banks. However, several limitations, such as a scarcity of organ donors for transplantation, are projected to limit market expansion. The demand for organs for organ failure treatment is far greater than the supply, which can be linked to a variety of religious and traditional views, as well as a lack of awareness regarding organ donation. During the projection period, the immunosuppressive medications segment is expected to grow at the fastest rate. This is due to the widespread use of these medications to prevent tissue or organ rejection after transplantation. Organ replacements are becoming more popular as the prevalence of chronic diseases rises. As a result, demand for immunosuppressive medications is likely to surge during the predicted period.

Organ and Tissue Transplantation Market

MARKET SUMMARY
-
7.7% CAGR
  • Study Period– 2021-2027
  • Base Year– 2020
  • CAGR– 7.7%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Organ and Tissue Transplantation Market

  • The report on global Organ and Tissue Transplantation Market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application, end user and geography.
  • Organ and Tissue Transplantation Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Hoffmann-La Roche Ltd. (Switzerland)
  • Novartis International AG (Switzerland)
  • OrganOX Limited (UK)
  • Terumo Medical Corporation (US)
  • Transonic (US)
Dynamics

Organ and Tissue Transplantation Market

Increase in the prevalence of chronic diseases and rising organ and tissue transplantation owing to organ damage or impairment is the key factor driving the growth of the market. The improving technology for organ and tissue transportation and transplantation is adding fuel for the growth of the market. The increasing investments in the research and development is providing opportunity for the growth of the market. However, the increasing incidence of the organ failures post-surgery is hampering the growth of the market. The limited number of donors is also and high cost involved in the treatment is expected to restrain the growth of the market. Lack of awareness regarding organ donation is likely to constrain the growth of the market.


North-America got significant share

Organ and Tissue Transplantation Market

Geographically, global organ and tissue transplantation market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North Americaorgan and tissue transplantation market growth is driven advanced technology. The increasing prevalence of the chronic diseases such as diabetes may cause renal failure which require organ transplantation. As per the National Kidney Foundation, there were approximately 122,737 patients waiting for the transplantation of their organs in the U.S. Following North America, are the regions of Europe and Asia Pacific. The Asia Pacific expected to grow at significant rate over the forecast period owing to its developing economy and huge patient pool.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2015-2020) and forecast (2021-2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenari0

Organ and Tissue Transplantation Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Hoffmann-La Roche Ltd. (Switzerland)
  • Novartis International AG (Switzerland)
  • OrganOX Limited (UK)
  • Terumo Medical Corporation (US)
  • Transonic (US)
  • Bio Med Pvt. Ltd. (US)
  • Transplant Biomedical (UK)
  • GlaxoSmithKline Plc. (UK)
  • Accord Healthcare GmbH (Spain)
  • Sanofi (France)
  • Pfizer, Inc. (US)

Description

The global organ and tissue transplantation market is expected to grow at a CAGR of 7.7% during the forecast period 2021 to 2027. Organ and tissue transplantation saves many lives and restores the essential functions of the body. The organ transplantation is the medical procedure in which the organ is removed from one body and is placed in the recipient’s body. The organs which can be transplanted include kidneys, heart, intestine, thymus, liver, lings and pancreas. The tissues include skin, cornea, heart valve, tendons and bones. The organ failure generally occurs owing to several conditions such as poising, serious trauma, drug abuse, and so on. The organ transplantation is the final stage of the treatment in organ failure. The organ and tissue transplantation market is also being boosted by the launch of technologically improved products and an increase in the number of tissue banks. However, several limitations, such as a scarcity of organ donors for transplantation, are projected to limit market expansion. The demand for organs for organ failure treatment is far greater than the supply, which can be linked to a variety of religious and traditional views, as well as a lack of awareness regarding organ donation. During the projection period, the immunosuppressive medications segment is expected to grow at the fastest rate. This is due to the widespread use of these medications to prevent tissue or organ rejection after transplantation. Organ replacements are becoming more popular as the prevalence of chronic diseases rises. As a result, demand for immunosuppressive medications is likely to surge during the predicted period.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX